Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 21 June

Paulina Peters
June 21, 2022

Morning Bell 20 June

Sophia Mavridis
June 20, 2022

Weekly Wrap 17 June

Sophia Mavridis
June 17, 2022

Morning Bell 16 June

Paulina Peters
June 16, 2022

Morning Bell 15 June

Sophia Mavridis
June 15, 2022

Morning Bell 14 June

Paulina Peters
June 14, 2022

Weekly Wrap 10 June

Sophia Mavridis
June 10, 2022

Morning Bell 9 June

Paulina Peters
June 9, 2022

Morning Bell 8 June

Sophia Mavridis
June 8, 2022

Morning Bell 7 June

Paulina Peters
June 7, 2022

Morning Bell 6 June

Sophia Mavridis
June 6, 2022